United States · Series C startup

Who invested in Menlo Therapeutics

One round we have observed, with the 8 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$50Mraised across 1 round since 2017, from 1 source

Latest round
Series C, $50MJul 2017
Investors
8
See who backed them

The rounds

  1. Jul 2017
    Series C$50M

    Reported by FinSMEsSEC filing: $51M sold, first sale Jul 2017

Founders and team

From the SEC filings it signed: 1 on the team.

  • Steven L. BastaExecutive Officer, Directori

On the board, as filediAaron L. RoystonAlbert L. ChaDavid L. CollierJohn L. CreecyKetan L. PatelScott L. WhitcupTed L. Ebel

Everyone who backed them

F-Prime CapitalVC firm1round
Bay City CapitalVC firm1round
PresidioPrivate equity1round
RemeditexGrowth equity1round
Rock VenturesFamily office1round
Aislingno record of our own yet1round
venBio/ Novono record of our own yet1round
Vivono record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Menlo Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Aisling CapitalPrivate equityPer its own site

Quick answers about Menlo Therapeutics

Who invested in Menlo Therapeutics?

Menlo Therapeutics's investors include F-Prime Capital, Bay City Capital, Presidio, Remeditex and Rock Ventures, and 3 more on record.

How much has Menlo Therapeutics raised?

Menlo Therapeutics has raised $50M across 1 round since 2017.

When did Menlo Therapeutics last raise?

Menlo Therapeutics's most recent round was a Series C of $50M in Jul 2017.

What was Menlo Therapeutics's biggest round?

Its most recent round, $50M in Jul 2017, is also its largest on record.

Who backed Menlo Therapeutics first?

Menlo Therapeutics's first round on record, in Jul 2017, was backed by F-Prime Capital, Bay City Capital and Presidio and 5 others.

What stage is Menlo Therapeutics at?

Menlo Therapeutics's latest named round is a Series C, in Jul 2017.

Where is Menlo Therapeutics based?

Menlo Therapeutics is based in the United States.

Companies like Menlo Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.